Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VIVITROL in adults with opioid dependence
NCT00678418Phase 3Completed
- Sponsor
- Alkermes
- Start
- Jun 2008
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of naltrexone in opioid use disorder (OUD), sponsored by Alkermes. Started Jun 2008; status: completed.
02
Drugs
naltrexone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT00678418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00678418.